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Abstract
Background: Renal failure is common in critically ill patients and frequently requires continuous renal replacement
therapy (CRRT). CRRT is discontinued at regular intervals for routine changes of the disposable equipment or for
replacing clogged filter membrane assemblies. The present study was conducted to determine if the necessity to
continue CRRT could be predicted during the CRRT-free period.
Materials and methods: In the period from 2003 to 2006, 605 patients were treated with CRRT in our ICU. A total
of 222 patients with 448 CRRT-free intervals had complete data sets and were used for analysis. Of the total CRRT-
free periods, 225 served as an evaluation group. Twenty-nine parameters with an assumed influence on kidney
function were analyzed with regard to their potential to predict the restoration of kidney function during the
CRRT-free interval. Using univariate analysis and logistic regression, a prospective index was developed and
validated in the remaining 223 CRRT-free periods to establish its prognostic strength.
Results: Only three parameters showed an independent influence on the restoration of kidney function during
CRRT-free intervals: the number of previous CRRT cycles (medians in the two outcome groups: 1 vs. 2), the
“Sequential Organ Failure Assessment"-score (means in the two outcome groups: 8.3 vs. 9.2) and urinary output
after the cessation of CRRT (medians in two outcome groups: 66 ml/h vs. 10 ml/h). The prognostic index, which
was calculated from these three variables, showed a satisfactory potential to predict the kidney function during the
CRRT-free intervals; Receiver operating characteristic (ROC) analysis revealed an area under the curve of 0.798.
Conclusion: Restoration of kidney function during CRRT-free periods can be predicted with an index calculated
from three variables. Prospective trials in other hospitals must clarify whether our results are generally transferable
to other patient populations.
Introduction
Acute impairment of kidney function is common in criti-
cally ill patients. Although the individual risk varies widely
depending on the underlying disease, the overall incidence
is 15-20% [1,2]. Secondary complications such as hypervo-
lemia or electrolyte disturbances can be effectively treated
by renal replacement therapy. Although their superiority
to intermittent therapies is not yet proven, continuous
renal replacement therapies (CRRT) are used predomi-
nantly in critically ill patients, because the gradual removal
of fluids is tolerated better, especially in hemodynamically
instable patients [3,4]. However, even continuous treat-
ments must be regularly interrupted because the
maximum operation time of disposable products is usually
limited to 72 hours. Moreover, blood clots in the filter car-
tridge and increasing flow resistance in the venous cathe-
ters can also require unscheduled cessation of therapy.
Most patients require several CRRT cycles but renal
function recovers in the vast majority of cases [5]. If there
are no mandatory indications for immediate continuation
of CRRT (e.g. severe hyperkalemia) during a CRRT-free
interval, the attending physician must carefully assess
whether a further treatment cycle is necessary or not. In
addition to medical considerations, this decision also
affects the utilization of resources because setting up
hemofiltration devices requires significant expenditures
with regard to personnel and material. At present, clini-
cians practice CRRT in very different ways [6], and there
are only a few evidence-based recommendations on how
CRRT should be performed [7], and at which point CRRT
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any medium, provided the original work is properly cited.should be started or discontinued [8]. To our knowledge,
only two studies on predicting the recovery of renal func-
tion during CRRT-free intervals have been published
[9,10]. Therefore, the aim of the present study was to eval-
u a t ew h e t h e rt h en e e df o raf u r t h e rC R R Tc y c l ec a nb e
determined on the basis of suitable parameters after cessa-
tion of a CRRT-cycle.
Materials and methods
Patients
In the period from 2003 to 2006, 7471 patients were
treated on our surgical ICU, of whom 605 required
CRRT. The only exclusion criterion was pre-existing
end-stage renal failure requiring dialysis. Complete data
sets for all CRRT-free intervals were available for 222
patients. There was a total of 448 CCRT-free intervals,
which were used for analysis.
Criteria for terminating and resuming CRRT
According to the standard operating procedures of our
ICU, the following two rules were strictly binding for
the decision to stop or restart CRRT:
￿ Every CRRT cycle is continued until either the fil-
ter is obstructed by clots or the maximum operating
time of the disposable CRRT material is reached, at
which time CRRT is stopped and the device disas-
sembled. This rule is also adhered to in patients
with increasing urinary output during CRRT,
because glomerular filtration is low in the early
stages of recovering renal function, and thus the full
excretory potential of the CRRT devices should be
exhausted.
￿ After termination of a CRRT cycle for the above-
mentioned reasons, anuria alone is not a sufficient
criterion to immediately start the next cycle. In fact,
CRRT is only restarted if hyperkalemia (> 5.5 mmol/
l), hypervolemia (evidenced by congestive heart fail-
ure, relevant edema or impaired oxygenation) or
profound uremia is present. There is no fixed
threshold for the last criterion; CRRT is continued
when patients with elevated serum urea levels have
neurological symptoms that cannot be explained by
other circumstances.
Definition of “CRRT-free intervals” and their outcome
A “CRRT-free” interval as defined for this study had to
meet two criteria: First, the CRRT cycle had to be actu-
ally terminated (CRRT device disassembled) and not sim-
ply temporarily interrupte d ,e . g .f o rd i a g n o s t i co r
therapeutic measures outside the ICU. Second, after ter-
mination of the CRRT cycle there was no compelling
need to restart CRRT immediately, meaning that either
of two outcomes i.e. restoration of an adequate urinary
output or the resumption of CRRT were theoretically
possible.
To assure that only CRRT-free periods as defined in the
protocol were included, we only analyzed CRRT-free
intervals that lasted 12 hours or longer. Using this cut-off
value, we were able to exclude with a high degree of cer-
tainty temporary interruptions of CRRT and CRRT-free
periods, in which it was obvious from the very beginning
that it would be necessary to continue the treatment.
Restoration of an adequate renal function was assumed
if the patients were discharged from the ICU and no
further renal replacement therapy was implemented dur-
ing the remaining hospital stay.
Data processing
Using the electronic patient data management system
“GISI” (Göttinger Informations-System für Intensivmedi-
zin), we identified all patients in whom CRRT had been
performed during the study period. A total of 448 CRRT-
free periods matching the study definition were identified
involving 222 patients. For each of these occasions, we
extracted a standardized set of 29 parameters with an
assumed influence on renal function. These parameters
contained either general information (i.e. gender or age) or
were related to the 12 hours immediately prior to or the
first eight hours following the cessation of CRRT. The
“Sequential Organ Failure Assessment"-score (SOFA
score) was calculated at each cessation of CRRT to assess
the severity of organ dysfunction. Tables 1 and 2 show the
complete listing of all analyzed parameters; data were
recorded anonymously in Microsoft Excel.
Statistical methods
The 448 data sets of the 222 patients were divided into an
evaluation group (the 225 data sets from the first 123
patients) and a validation group (the remaining 223 data-
sets from 99 patients). Depending on the clinical course,
each CRRT-free interval was allocated to one of two out-
come groups: “CRRT continued” if clinical conditions
required resumption of renal replacement therapy, or
“Recovery of kidney function” if patients were discharged
from the ICU and no further CRRT was necessary.
In the evaluation group, all 27 continuous parameters
were tested for normal distribution using the D’Agos-
tino-Pearson test. Next, all parameters were tested uni-
variately for having different distributions in the two
outcome groups. For continuous variables with normal
distribution we used Student’s t-test for independent
samples, and for those without normal distribution we
used the Mann-Whitney rank-sum test. For all categori-
cal values, we used a c
2-test. Afterwards, all parameters
with different distributions in the outcome groups were
subjected to logistic regression to assess their
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tion of adequate renal function”.
Based on the regression equation (resulting from
logistic regression), a formula was developed to calculate
the logit(p) value for each CRRT-free interval, which in
turn is a measure of the probability of the desirable out-
come (i.e. restoration of a sufficient kidney function)
[11]. Accordingly, the logit(p) value was calculated for
all 223 CRRT-free intervals of the validation group.
ROC-analysis was performed to calculate sensitivity and
specifity of the logit(p) value to identify patients with
recovering kidney function.
For all tests, the level of statistical significance was set
at p < 0.05. Calculations were performed with Medcalc
®
software (Medcalc, Mariakerke, Belgium).
Results
Patients and general data
Between 2003 and 2006, 222 patients in the surgical
i n t e n s i v ec a r eu n i tw e r et r e a t e dw i t hC R R Tf o ra c u t e
renal failure after cardiac surgery. One hundred forty-
four of the patients were male, and 78 were female. The
median age was 71 years (IQR: 66 - 77 years); median
height 169 cm (IQR: 163 - 175 cm) and median weight
Table 1 Univariate analysis of continuous parameters within the evaluation group.
Outcome of CRRT-free interval p-value
Recovery of kidney function
N = 103
Resumption of CRRT
N = 122
General Data
Age (years) 70 (IQR: 65-77) 74 (IQR: 61-78) 0.66
2
SOFA score 8.3 (SD: 3.62) 9.2 (SD: 3.78) 0.042
1
Number of CRRT cycles 1 (IQR: 1-1.75) 2 (IQR: 1-4) < 0.0001
2
Fluid balance
(during the last 12 h of CRRT)
Total balance (ml) -315 (IQR: -807 to 214) -336 (IQR: -1148 to 314) 0.74
2
Urine output (ml/h) 33 (IQR: 14.2-54.2) 8 (IQR: 0-20) < 0.0001
2
Infused synthetic colloids (ml) 0 (IQR: 0-0) 0 (IQR: 0-0) 0.61
2
Fluid balance
(first 8 h after end of CRRT)
Total balance (ml) 443 (IQR: 43-1133) 909 (IQR: 502-1361) 0.0003
2
Urine output (ml/h) 66 (IQR: 29-122) 10 (IQR: 0-29) < 0.0001
2
Infused synthetic colloids (ml) 0 (IQR: 0-0) 0 (IQR: 0-0) 0.46
2
Inotropes and vasoactive drugs
(8 h-maximum after end of CRRT)
Norepinephrine (μg/min) 0 (IQR: 0-0) 0 (IQR: 0-0) 0.28
2
Epinephrine (μg/min) 0 (IQR: 0-0) 0 (IQR: 0-0) 0.35
2
Dobutamine (μg/kg/min) 0 (IQR: 0-0) 0 (IQR: 0-0) 0.45
2
Hemodynamics
(Averaged 8 h after end of CRRT)
Mean arterial pressure (mmHg) 77 (IQR: 71-84) 73 (IQR: 67-80) 0.013
2
Central venous pressure (mmHg) 11.2 (IQR: 8.6-15.3) 12.8 (IQR: 10.0-16.1) 0.049
2
Heart rate (1/min) 86 (IQR: 77-94) 89 (IQR: 81-96) 0.053
2
Laboratory values
(first value after end of CRRT)
Na+ (mmol/l) 139.9 (SD: 3.1) 139.6 (SD: 3.0) 0.49
1
K+ (mmol/l) 4.65 (IQR: 4.44-4.91) 4.70 (IQR: 4.40-4.90) 0.58
2
Creatinine (mg/dl) 1.90 (IQR: 1.50-2.60) 2.05 (IQR: 1.40-2.70) 0.98
2
Urea (mg/dl) 52.4 (SD: 17.7) 52.9 (SD: 19.6) 0.83
1
pH 7.45 (IQR: 7.42-7.48) 7.44 (IQR: 7.40-7.47) 0.018
2
Standard bicarbonate (mmol/l) 26.4 (IQR: 24.4-28.6) 26.0 (IQR: 24.2-27.7) 0.17
2
Hemoglobin (mg/dl) 9.8 (IQR: 9.2-10.6) 9.4 (IQR: 8.7-10.4) 0.014
2
Furosemide
(first 8 h after end of CRRT)
Total i.v. dose (mg) 50 (IQR: 0-100) 0 (IQR: 0-0) < 0.0001
2
Normally distributed data were analyzed with the t-test for independent samples
(1), not-normally distributed data with the Mann-Whitney-test
(2).
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formed were coronary artery bypass graft (CABG, n =
94), valve surgery (n = 60), combined CABG and valve
surgery (n = 39) and other cardiac surgery (n = 29). The
median SOFA score was 8 with an IQR of 6 to 11.
Although the number of CRRT-cycles ranged from 1
to 14, the median was 1 with an interquartile range of 1
- 3 cycles. As only CRRT-free periods with a minimum
duration of 12 hours were included into the study, their
median duration was 23.6 hours (IQR: 14.6 - 45.4
hours).
Univariate analysis
In the evaluation group, 11 of the 27 parameters showed
statistically significant differences between the two out-
come-groups: SOFA score, number of previous CRRT
cycles, urinary output over the last 12 hours before ces-
sation of CRRT, fluid balance and urinary output over
the first 8 hours after cessation of CRRT, mean arterial
and central venous pressures (both averaged over the
first 8 hours after cessation of CRRT), arterial pH,
hemoglobin concentration, total dose of furosemide and
administration of any other diuretics during the first 8
hours after cessation of CRRT (tables 1 and 2).
Multivariate analysis (logistic regression)
Multivariate analysis of these parameters showed an
independent influence on the outcome of CRRT-free
intervals for three variables: SOFA score, number of
previous CRRT cycles and urinary output during the first
8 hours after cessation of CRRT (Table 3). The overall
model fit statistic was assessed using the Likelihood Ratio
Test which revealed a high goodness-of-fit (p < 0.0001).
Entering the regression coefficients into the regression
equation, the following formula resulted to calculate the
logit(p) value from the three clinical variables:
logit(p) = 1.695−0.174∗SOFA−0.802∗number of CRRT cycles+0.026∗urinary output

ml/h

ROC-Analysis (Figure 1)
ROC-analysis of the calculated logit(p) values from the
validation group revealed a sensitivity of 73.5% (95% CI:
61.4%-83.5%) and a specifity of 74.2% (95% CI: 66.6%-
80.9%) for the identification of patients who would not
require further CRRT. The optimal cut off point was a
logit(p) value of 0.684, the area under the ROC-curve
was 0.798 (95% CI: 0.740-0.894).
Discussion
After termination of a CRRT-cycle, our score allows the
prediction of whether another CRRT-cycle will be
necessary or the kidneys will begin to function ade-
quately. For the practical application two characteristics
of the score are noteworthy: First, the index can be cal-
culated timely, i.e. 8 hours after cessation of a CRRT
cycle. Second, ROC-analysis gave an area under the
curve of 0.798, which reflects a considerable discrimina-
tive power as measured by sensitivity and specifity.
Table 2 Univariate analysis of categorical parameters within the evaluation group using c
2-test
Outcome of CRRT-free interval p-value
Recovery of kidney function
N = 103
Resumption of further CRRT
N = 122
Gender 0.37
Male 71 (68.9%) 76 (62.3%)
Female 32(31.1%) 46 (37.7%)
Chronic kidney disease 0.17
Yes (GFR < 60 ml/min/1,73 m
2) 54 (52.4%) 76 (62.3%)
No (GFR ≥ 60 ml/min/1,73 m
2) 49 (47.6%) 46 (37.7%)
Respiration after end of CRRT 0.13
Spontaneous breathing 61 (59.2%) 85 (69.7%)
Mechanically ventilated 42 (40.8%) 37 (30.3%)
Atrial fibrillation after end of CRRT 0.26
Yes 29 (28.2%) 44 (36.1%)
No 74 (71.8%) 78 (63.9%)
Diuretics other than Furosemide < 0.0001
Yes 45 (43.7%) 15 (12.3%)
No 58 (56.3%) 107 (87.7%)
Drugs with potential negative
effect on renal function
0.051
Yes 6 (5.8%) 18 (14.8%)
No 97 (94.2%) 104 (85.2%)
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than 90% of the patients [12], most renal replacement
therapies are only temporary measures, and physicians
must assess after each CRRT-cycle if another treatment
cycle is necessary or not. In some ICUs, it is common
practice to continue CRRT immediately after the end of
a CRRT cycle (e.g. after the maximum operation time of
the disposables has been reached), even if there is no
mandatory indication for continuation. However, though
many clinical trials have addressed this topic, no evi-
dence exists at present showing that patients have any
benefit from this kind of gapless therapy [13,14]. More-
over, even intermittent therapies have been proven to be
as safe as CRRT for the vast majority of critically ill
patients [3,4]. It is therefore also an absolutely reason-
able approach to refrain from immediately continuing
CRRT, if there are no clear indications for it, such as
increasing serum potassium or volume overload. In
addition to the medical and organizational impact, the
decision to continue also has financial implications, as
the disposable parts for a hemofiltration device alone
cost about 250 € (roughly 330 USD) [15]. Against this
background, a tool to predict the necessity of continuing
CRRT may contribute to this decision in a helpful way.
When this study was planned, the most important
prerequisite was a thorough assessment of the para-
meters with an assumed influence on renal function. An
intensive search of the literature confirmed the influence
of parameters such as arterial hypotension [16], hypovo-
lemia [17], mechanical ventilation [18], the use of drugs
with potentially harmful effects on kidney function [19]
and the use of synthetic colloids [20]. All of these could
be efficiently assessed from our electronic patient data
management system. Additionally, we examined 16
other parameters with an assumed influence on kidney
function for our statistical analysis, which also were
obtained completely from the electronic patient data
management system.
The comparison of our study design with those of Wu
[9] and Uchino [10] is also of interest. With regard to
the composition of the analyzed risk factors, all three
trials integrated both general data (e.g. age, sex) and
data which were variable at the end of each individual
CRRT-cycle (such as fluid balance, hemodynamics etc.).
However, Wu and coworkers did not take hemodynamic
parameters into account, though it is known that hemo-
dynamic instability is an important risk factor for acute
kidney failure. On the whole, the resulting set of all ana-
lyzed risk factors in our trial is similar to the total of the
risk factors chosen by Wu and Uchino.
It is interesting to note that serum concentrations of
creatinine and urea after cessation of CRRT showed no
significant differences between the two outcome groups
in our study (creatinine: median 1.90 mg/dl and 2.05
mg/dl, p = 0.98, urea: mean 52.4 mg/dl and 52.9 mg/dl,
p = 0.83). In addition to the serum concentrations, the
increase of retention parameters can also be of interest
for the assessment of kidney function. For instance,
Ishani and coworkers found that the increase in serum
creatinine might predict the progress of chronic kidney
disease [21]. However, they analyzed the slope between
baseline and peak serum creatinine level, which nor-
mally takes several days to reach. In contrast, our score
was designed to predict the outcome of a CRRT-free
interval soon after cessation of CRRT, wherefore it con-
sists solely of data that can be retrieved within 8 hours
after termination of CRRT. Due to the very slow rate of
Table 3 Results of logistic regression within the evaluation group (endpoint: Restoration of a sufficient renal function)
Variable Regression
coefficient
Odds ratio Odds ratio
95% CI
p
SOFA-score -0.174 0.840 0.751 - 0.939 0.0022
Number of CRRT cycles -0.802 0.449 0.307 - 0.656 < 0.0001
Urinary output (ml/h) 0.026 1.026 1.017 - 1.036 < 0.0001
Constant 1.695
Figure 1 Sensitivity and specificity of the calculated prognostic
index for the prediction of recovery of renal function during
CRRT-free periods.
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did not analyze their increase after such a short time
interval.
Of the parameters that showed different distributions
in the two outcome groups, most of the differences
were consistent with the expectations based on knowl-
edge of renal injury. For example, mean arterial pres-
sure, hemoglobin concentration and pH-value were
higher in patients with recovering kidney function dur-
i n gC R R T - f r e ei n t e r v a l s( t a b l e1 ) .T h eo n l ye x c e p t i o n s
were the total furosemide dose and the use of diuretics
other than furosemide, which were both far higher in
those patients who developed a satisfactory renal func-
tion during the CRRT-free intervals (furosemide dose in
8 hours: 82 mg vs. 18 mg, other diuretics: 45 out of 103
i n t e r v a l sv s .1 5o u to f1 2 2i n t e r v a l s ) .T h i si sar e m a r k -
able finding because current data suggest that the
potentially harmful effects of diuretics to an injured kid-
ney can cancel out their benefit. Although a high urine
flow might protect the tubular system from obstruction
by cell detritus or sludge [22], diuretics can reduce
medullar tonicity, which in turn might reduce renal
blood flow [23]. In addition, diuretic-induced hypovole-
mia could aggravate prerenal causes of renal failure. The
standard operating procedure in our ICU therefore pro-
hibits the use of diuretics if the urinary output is below
0.3 ml/kg/h. Thus, the remarkably higher doses of diure-
tics in patients who did not need further CRRT are
probably a consequence of recovering renal function,
rather than its cause.
Basically, our results are concordant with the findings
of Uchino and coworkers, who also investigated the pos-
sibility of predicting the outcome of CRRT-free periods
[10]. In their trial, the amount of diuresis during CRRT
also had a good discriminative power to predict the
necessity of further renal replacement therapy. In con-
trast to their findings, serum creatinine was not signifi-
cantly different between the two outcome groups in our
trial. Moreover, Uchino only tested the discriminative
power of two single parameters (urinary output and
serum creatinine), but did not integrate them using an
equation as we did. This simplifies the prediction,
because no extensive calculations are required. However,
the combination of several factors with an independent
influence on the outcome may increase sensitivity and
specifity of the prognosis [24]
A strongpoint of the present study is that all 27 para-
meters with an assumed influence on renal function
were available in their entirety without any missing data.
Moreover, hemodynamic parameters and fluid balances
were recorded at one-minute intervals, which allowed
for an analysis with a high degree of precision. In con-
trast, a primary weakness of the trial is its limitation to
these 448 data sets. Obtaining a greater number of data
sets would have required the analysis of patient data
from a period significantly longer than three years or
would have required a multicenter approach. This
would have resulted in an increased inconsistency of
treatment standards, and so the analysis of a 3-year
interval was chosen as a suitable compromise between
volume and homogeneity of the data sets. Due to the
specialization of our ICU, only patients after cardiac sur-
gery were included in the analysis, which is another lim-
itation of the study.
Conclusion
Only three of a total of 27 studied parameters showed
an independent influence on the recovery of renal func-
tion after cessation of CRR T :S O F As c o r e ,n u m b e ro f
previous CRRT cycles and urinary output after termina-
tion of CRRT. Nevertheless, a prognostic index based
on these variables showed satisfactory power to predict
the outcome of CRRT-free intervals in a separate valida-
tion group. To assess the general suitability of our
results, validation in patients from other centers is
required.
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